Search Tag: Novavax

2023 09 Jan

Current President & CEO  Stanley C. Erck  will retire effective  January 23  with plans to support the leadership transition in an advisory capacity Novavax is well-positioned to execute on its strategy, with global authorizations for its COVID-19 vaccine and continued clinical pipeline development Novavax, Inc., a biotechnology company...Read more

2021 22 Dec

The European Commission granted conditional marketing authorisation for Novavax’s COVID-19 Vaccine for individuals 18 years or older. The U.S. biotech, Novavax , currently holds emergency use authorisations for its two-dose vaccine in the Philippines and Indonesia and has received emergency use listing from the World Health Organization. Unlike...Read more